Ryvu Therapeutics to Present at the 32nd Annual ROTH Conference

Krakow, Poland – 5 March 2020 – Ryvu Therapeutics (WSE: RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology, has been invited to participate in the 32nd Annual ROTH Conference held at The Ritz Carlton, Laguna Niguel in Orange County, CA, on March 15-17, 2020.


Chief Executive Officer Pawel Przewiezlikowski will take part in a fireside chat on Monday, March 16 at 3:00PM (PST).

The company’s presentation will be webcast and available here.


The ROTH Conference
, with close to 550 participating companies and over 5,100 attendees, will feature presentations from public and private companies in a variety of sectors that include life science, healthcare, technology services, and many more. The event is designed to bring executives, enthusiasts, and quality investors together and provide a unique opportunity to share and gain insight on the latest trends and unique innovations shaping the future.

 

For additional information or to schedule a one-on-one meeting with Ryvu Therapeutics management, please contact us at ir@ryvu.com.